Mr Vivek Asthana, Head EHS & Sustainability, Symbiotec Pharmalab
In this video:
Mr Vivek Asthana, Head EHS & Sustainability, Symbiotec Pharmalab
Topic: Sustainability as strategy: The next frontier for pharma leaders
Key Takeaways:
[1] ESG is no longer optional for the pharma industry. It is fundamental to survival, credibility and growth.
[2] Today, regulators like Securities and Exchange Board of India are mandating ESG disclosures through BRSR. Global frameworks are tightening.
[3] Investors are evaluating not just financial returns, but how responsibly those returns are generated. Customers and global buyers are increasingly choosing partners who are ethical, transparent and sustainable.
The post Mr Vivek Asthana, Head EHS & Sustainability, Symbiotec Pharmalab appeared first on Express Pharma.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
